Trial Profile
Ocular tissue levels of 1.5 percent levofloxacin ophthalmic solution compared to an active comparator [moxifloxacin]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2009
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary) ; Levofloxacin; Moxifloxacin
- Indications Bacterial infections; Ophthalmic infections
- Focus Pharmacokinetics
- Sponsors Santen Incorporated
- 04 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Mar 2008 New trial record.